ATE553378T1 - Screening und behandlungsverfahren zur vorbeugung von frühgeburten - Google Patents

Screening und behandlungsverfahren zur vorbeugung von frühgeburten

Info

Publication number
ATE553378T1
ATE553378T1 AT08005572T AT08005572T ATE553378T1 AT E553378 T1 ATE553378 T1 AT E553378T1 AT 08005572 T AT08005572 T AT 08005572T AT 08005572 T AT08005572 T AT 08005572T AT E553378 T1 ATE553378 T1 AT E553378T1
Authority
AT
Austria
Prior art keywords
screening
subject
prevent premature
treatment procedures
premature birth
Prior art date
Application number
AT08005572T
Other languages
English (en)
Inventor
Durlin Hickok
Robert Hussa
Mark Fischer-Colbrie
Emory V Anderson
Andrew E Senyei
Original Assignee
Hologic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hologic Inc filed Critical Hologic Inc
Application granted granted Critical
Publication of ATE553378T1 publication Critical patent/ATE553378T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08005572T 2003-02-06 2004-02-06 Screening und behandlungsverfahren zur vorbeugung von frühgeburten ATE553378T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44628803P 2003-02-06 2003-02-06
US46652603P 2003-04-28 2003-04-28
US49070603P 2003-07-28 2003-07-28

Publications (1)

Publication Number Publication Date
ATE553378T1 true ATE553378T1 (de) 2012-04-15

Family

ID=32872757

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08005572T ATE553378T1 (de) 2003-02-06 2004-02-06 Screening und behandlungsverfahren zur vorbeugung von frühgeburten

Country Status (5)

Country Link
US (1) US20040266025A1 (de)
EP (2) EP1590668A2 (de)
AT (1) ATE553378T1 (de)
CA (1) CA2512989A1 (de)
WO (1) WO2004071427A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US20050191704A1 (en) * 2004-03-01 2005-09-01 Kimberly-Clark Worldwide, Inc. Assay devices utilizing chemichromic dyes
AU2005280528B2 (en) 2004-07-30 2010-12-23 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
US20080090759A1 (en) * 2004-08-30 2008-04-17 Robert Kokenyesi Methods and kits for predicting risk for preterm labor
PL2083863T3 (pl) 2006-10-03 2015-08-31 Genzyme Corp Przeciwciała przeciwko TGF-beta do stosowania w leczeniu niemowląt obarczonych ryzykiem rozwinięcia się dysplazji oskrzelowo-płucnej
WO2008070467A2 (en) * 2006-12-01 2008-06-12 Joseph Thomas Weishaar Method for preventing chronic disease
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
WO2010009514A1 (en) * 2008-07-25 2010-01-28 Newcastle Innovation Limited Methods and kits for predicting the onset of labour
GB0905964D0 (en) * 2009-04-06 2009-05-20 King S College London Marker
FI123297B (fi) * 2009-05-04 2013-02-15 Valtion Teknillinen Lateraalivirtausmäärityksen testiliuska ja sen valmistusmenetelmä
EP2544707B1 (de) * 2010-03-09 2018-11-21 Dignity Health Verfahren zur unterdrückung von frühgeburtschmerzen und gebärmutterkontraktionsstörungen sowie zur verhinderung von gebärmutterreizungen
FR2960974B1 (fr) * 2010-06-03 2016-12-30 Biosynex Procede de detection de rupture de membranes
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
WO2012021944A1 (en) * 2010-08-20 2012-02-23 Newcastle Innovation Ltd Methods and kits for predicting the onset of labour
US8765487B2 (en) * 2010-09-01 2014-07-01 Clinical Innovations Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
US11555816B2 (en) 2010-09-01 2023-01-17 Clinical Innovations, Llc Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
US10338065B2 (en) * 2010-09-01 2019-07-02 Clinical Innovations, Llc Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
KR101888213B1 (ko) * 2010-10-01 2018-08-13 홀로직, 인크. 진단 시스템에 사용하기 위한 면역분석 시험 스트립
US9271991B2 (en) 2010-10-27 2016-03-01 Dignity Health Trimegestone (TMG) for treatment of preterm birth
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
CA2847257A1 (en) 2011-09-16 2013-03-21 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pre-term birth
WO2014066568A1 (en) 2012-10-24 2014-05-01 Winthrop-University Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
EP3180611B1 (de) 2014-08-12 2025-04-09 NextGen Jane, Inc. System und verfahren zur überwachung der gesundheit auf basis von gesammelter körperflüssigkeit
MX2017016823A (es) * 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
US9903866B2 (en) * 2016-04-05 2018-02-27 Conquerab Inc. Portable devices for detection of antibodies against therapeutic drugs
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods
EP3682250A4 (de) 2017-09-13 2021-03-03 Progenity, Inc. Präeklampsie-biomarker sowie zugehörige systeme und verfahren
WO2019152657A1 (en) * 2018-02-03 2019-08-08 Simple Healthkit, Inc. Reliable, comprehensive, and rapid sexual health assessment
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
CN113616660A (zh) * 2020-05-07 2021-11-09 深圳埃格林医药有限公司 孕激素制剂及其用途
US12426782B2 (en) 2020-11-06 2025-09-30 The Board Of Trustees Of The Leland Stanford Junior University Systems and temporal alignment methods for evaluation of gestational age and time to delivery
CN115093475A (zh) * 2022-07-08 2022-09-23 安徽惠邦生物工程有限公司 阴道分泌物胰岛素样生长因子结合蛋白-1提取液及其制备方法
CN115144598B (zh) * 2022-09-02 2023-03-10 山东子峰生物技术有限公司 一种胎儿纤维结合蛋白和胰岛素生长因子结合蛋白-1的量子点荧光检测方法及应用
CN120787316A (zh) * 2022-10-21 2025-10-14 科瑞生物股份有限公司 具有羊水标志物检测试纸条的穿戴物品

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894326A (en) 1986-04-09 1990-01-16 Fred Hutchinson Cancer Research Center Monoclonal antibody defining oncofetal structure of fibronectin
US5132097A (en) 1987-02-11 1992-07-21 G.D. Research Apparatus for analysis of specific binding complexes
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
US5223440A (en) 1987-11-17 1993-06-29 Adeza Biomedical Corporation Ex vivo product of conception test to determine abortion
US5185270A (en) 1987-11-17 1993-02-09 Adeza Biomedical Corporation Fetal fibronectin pregnancy test
US5096830A (en) 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
US4919889A (en) 1988-09-15 1990-04-24 Aspen Diagnostics Corporation Sample collection and transport fluid composition
US5079171A (en) 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
US5281522A (en) 1988-09-15 1994-01-25 Adeza Biomedical Corporation Reagents and kits for determination of fetal fibronectin in a vaginal sample
US5252459A (en) 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US5236846A (en) 1988-11-18 1993-08-17 Adeza Biomedical Corporation Ectopic pregnancy test
US5211952A (en) 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
WO1993009432A1 (en) 1991-11-04 1993-05-13 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US5516702A (en) 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
AU5142193A (en) 1992-09-28 1994-04-26 Biex, Inc. Method for prediction of premature labor
JP3742649B2 (ja) 1993-01-22 2006-02-08 アデザ・バイオメデイカル・コーポレイシヨン 切迫分娩についての危険にある女性における膜の破裂を決定するための検定方法
US5500375A (en) 1993-04-13 1996-03-19 Serex, Inc. Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats
US5370135A (en) 1993-10-13 1994-12-06 Biex, Inc. Use of estriol measurement to monitor tocolytic therapy
US5650394A (en) * 1993-11-04 1997-07-22 Adeza Biomedical Use of urinastatin-like compounds to prevent premature delivery
US5597700A (en) 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
US5658801A (en) 1994-05-03 1997-08-19 Spectral Diagnostics Inc. Medical test kit
US5786227A (en) 1995-06-07 1998-07-28 Biex, Inc. Fluid collection kit and method
US5656502A (en) 1995-06-07 1997-08-12 Diagnostic Chemicals Limited Test strip holder and method of use
US5786228A (en) 1995-06-07 1998-07-28 Biex, Inc. Fluid collection kit and method
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6375970B1 (en) * 1999-07-07 2002-04-23 Andre Bieniarz Methods and materials for preterm birth prevention
FR2813840B1 (fr) 2000-09-13 2003-04-04 Bosch Gmbh Robert Servofrein

Also Published As

Publication number Publication date
EP1936376B1 (de) 2012-04-11
EP1936376A2 (de) 2008-06-25
EP1936376A3 (de) 2009-04-01
EP1590668A2 (de) 2005-11-02
WO2004071427A2 (en) 2004-08-26
WO2004071427A3 (en) 2005-04-14
CA2512989A1 (en) 2004-08-26
US20040266025A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
ATE553378T1 (de) Screening und behandlungsverfahren zur vorbeugung von frühgeburten
EA200801071A1 (ru) Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием
TR200101769T2 (tr) Biyolojik maddelerin uygulanmasını kolaylaştıran cihazlar ve işlemler.
EA200801698A1 (ru) Лекарственные композиции для применения в вагине
Pryor et al. Delayed timing of intrauterine insemination results in a significantly improved pregnancy rate in female partners of quadriplegic men
BRPI0407213A (pt) Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados
Sanoulis et al. The use of plateletrich plasma in the gynaecological clinical setting. A review
Al-Benna et al. Postablative reconstruction is better terminology than oncoplastic surgery
US20040059190A1 (en) Method of colpoplasty
EP1804789A4 (de) Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin
Muhajir et al. Correlation between swelling post odontectomy in lower third molar with the increase of concentration alpha amylase saliva
Koller et al. Abdominoplasty flap elevation more superficially
Bowers Aesthetic male‐to‐female transsexual surgery
BROWN Osteomyelitis of the frontal bone
Nawaz et al. Outcome of Fast Track Surgery (FTS) or Enhanced Recovery after Surgery (ERAS) in Major Gynecological Surgeries
RU2281748C2 (ru) Способ коррекции гормональных и иммунных нарушений у больных гормонально зависимыми заболеваниями
Farage et al. The vulva
Cantarella et al. Simultaneous Sarles and transverse perineal support operation for the treatment of occult rectal prolapse, rectocele and perineal descent in patients with obstructed defecation syndrome
Çeltik et al. Health-related quality of life in patients undergoing surgery for upper extremity bone tumors: A cross-sectional study
MD3222G2 (ro) Metodă de diagnostic al cancerului endometrial
Low F Diagnostic US provides critical information in the evalu-ation. The ATA identifies size criteria and sonographic features of nodules that allow risk stratification.
Radionov et al. Crypto-glandular fistulous paraproctites-is the surgical prophylaxis of reccurences imperative?
Savage et al. Microbiological investigation of the mandibular condyle in patients with advanced osteoarthritis of the temporomandibular joint
RU2412724C1 (ru) Способ лечения воспалительного очага
Makhlouf Brachioplasty incision